A detailed history of Algert Global LLC transactions in Glaukos Corp stock. As of the latest transaction made, Algert Global LLC holds 5,054 shares of GKOS stock, worth $658,435. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,054
Holding current value
$658,435
% of portfolio
0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$89.48 - $118.35 $452,231 - $598,140
5,054 New
5,054 $598,000
Q2 2021

Aug 13, 2021

SELL
$73.06 - $97.7 $202,814 - $271,215
-2,776 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$70.43 - $97.42 $195,513 - $270,437
2,776 New
2,776 $233,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.2B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.